Boston Partners Has $43.56 Million Position in LifePoint Health Inc (NASDAQ:LPNT)

Boston Partners grew its holdings in shares of LifePoint Health Inc (NASDAQ:LPNT) by 50.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 874,690 shares of the company’s stock after buying an additional 294,480 shares during the quarter. Boston Partners owned 2.22% of LifePoint Health worth $43,559,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in LPNT. Wells Fargo & Company MN grew its holdings in LifePoint Health by 2.0% during the 2nd quarter. Wells Fargo & Company MN now owns 22,394 shares of the company’s stock valued at $1,504,000 after purchasing an additional 443 shares during the last quarter. Teachers Advisors LLC grew its holdings in LifePoint Health by 1.3% during the 2nd quarter. Teachers Advisors LLC now owns 65,909 shares of the company’s stock valued at $4,426,000 after purchasing an additional 836 shares during the last quarter. Ameriprise Financial Inc. grew its holdings in LifePoint Health by 5.5% during the 2nd quarter. Ameriprise Financial Inc. now owns 118,101 shares of the company’s stock valued at $7,931,000 after purchasing an additional 6,116 shares during the last quarter. Thrivent Financial For Lutherans grew its stake in LifePoint Health by 7.4% in the 2nd quarter. Thrivent Financial For Lutherans now owns 8,130 shares of the company’s stock worth $546,000 after acquiring an additional 560 shares in the last quarter. Finally, Vanguard Group Inc. grew its stake in LifePoint Health by 1.3% in the 2nd quarter. Vanguard Group Inc. now owns 3,310,467 shares of the company’s stock worth $222,299,000 after acquiring an additional 43,504 shares in the last quarter.

A number of brokerages have commented on LPNT. BidaskClub upgraded shares of LifePoint Health from a “sell” rating to a “hold” rating in a research note on Thursday, January 11th. William Blair restated an “outperform” rating on shares of LifePoint Health in a research note on Tuesday, November 21st. Credit Suisse Group initiated coverage on shares of LifePoint Health in a research note on Thursday, November 2nd. They issued a “neutral” rating and a $54.00 target price on the stock. Robert W. Baird set a $55.00 price objective on shares of LifePoint Health and gave the company a “buy” rating in a research note on Monday, October 30th. Finally, Raymond James Financial reiterated a “market perform” rating on shares of LifePoint Health in a research note on Monday, October 30th. One investment analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and five have issued a buy rating to the company’s stock. LifePoint Health currently has an average rating of “Hold” and an average price target of $58.67.

In other news, Director Marguerite Kondracke sold 3,907 shares of the stock in a transaction on Tuesday, November 28th. The shares were sold at an average price of $44.73, for a total value of $174,760.11. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider David M. Dill sold 45,000 shares of the stock in a transaction on Tuesday, January 16th. The stock was sold at an average price of $48.52, for a total transaction of $2,183,400.00. Following the completion of the sale, the insider now owns 252,673 shares in the company, valued at approximately $12,259,693.96. The disclosure for this sale can be found here. Company insiders own 8.76% of the company’s stock.

LifePoint Health Inc (NASDAQ:LPNT) opened at $49.10 on Thursday. The stock has a market cap of $1,939.26, a price-to-earnings ratio of 11.61, a price-to-earnings-growth ratio of 1.13 and a beta of 0.52. LifePoint Health Inc has a fifty-two week low of $42.50 and a fifty-two week high of $67.95. The company has a quick ratio of 1.65, a current ratio of 1.85 and a debt-to-equity ratio of 1.24.

LifePoint Health announced that its board has authorized a share buyback program on Friday, October 27th that allows the company to repurchase $200.00 million in outstanding shares. This repurchase authorization allows the company to reacquire shares of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board of directors believes its shares are undervalued.

COPYRIGHT VIOLATION NOTICE: “Boston Partners Has $43.56 Million Position in LifePoint Health Inc (NASDAQ:LPNT)” was originally reported by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this piece on another website, it was illegally copied and republished in violation of international copyright & trademark laws. The original version of this piece can be accessed at https://stocknewstimes.com/2018/02/22/boston-partners-raises-position-in-lifepoint-health-inc-lpnt.html.

LifePoint Health Profile

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Institutional Ownership by Quarter for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply